World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
38
Citations
5116
World Ranking
8601
National Ranking
3658

Overview

Richard Grondin is affiliated with the University of Kentucky in the United States. Their research primarily spans the fields of Medicine and Neuroscience, with a focus on subfields including Cellular and Molecular Neuroscience, Psychiatry and Mental Health, Neurology, and Radiology, Nuclear Medicine, and Imaging.

The scientist's recent publications demonstrate a concentration on neurological disorders and treatments, cerebrospinal fluid and hydrocephalus, epilepsy research and treatment, as well as advanced MRI techniques and nerve injury and regeneration. Key topics related to their work include:

  • Cerebrospinal fluid and hydrocephalus
  • Epilepsy research and treatment
  • Neurological disorders and treatments
  • Advanced MRI Techniques and Applications
  • Nerve injury and regeneration

Grondin has authored scholarly articles across several publication venues, notably:

  • Journal of Neuroscience Methods
  • Medical Research Archives
  • Applied Sciences

Their recent papers include:

  • "In-vitro and in-vivo performance studies of a porous infusion catheter designed for intraparenchymal delivery of therapeutic agents of varying size," 2022, Journal of Neuroscience Methods
  • "Surgical methodology and protocols for preventing implanted cerebral catheters from becoming obstructed during and after neurosurgery," 2020, Journal of Neuroscience Methods
  • "Comparative Studies of Continuous Versus Pulsatile Delivery of a Novel Mammalian Cell-Derived Variant of GDNF (GDNFv) into the Rhesus Macaque Striatum," 2024, Medical Research Archives
  • "Limosilactobacillus reuteri in Pediatric Oral Health: A Systematic Review," 2025, Applied Sciences

Frequent collaborators in Grondin's research include Greg A. Gerhardt, François Pomerleau, Jorge E. Quintero, Yi Ai, and Don M. Gash.

Best Publications

  • Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease

    Navin Maswood;Jennifer Young;Edward Tilmont;Zhiming Zhang

  • Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys.

    R. Grondin;P.J. Bédard;A. Hadj Tahar;L. Grégoire

  • Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys

    Richard Grondin;Zhiming Zhang;Ai Yi;Wayne A. Cass

  • Point source concentration of GDNF may explain failure of phase II clinical trial.

    Michael Francis Salvatore;Yi Ai;Brent Fischer;Amanda M. Zhang

  • Chronic Alterations in Dopaminergic Neurotransmission Produce a Persistent Elevation of ΔFosB-like Protein(s) in both the Rodent and Primate Striatum

    J P Doucet;Y Nakabeppu;P J Bedard;B T Hope

  • Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum

    Richard Grondin;Michael D. Kaytor;Yi Ai;Peter T. Nelson

  • Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson’s disease

    R. Grondin;Don M. Gash

  • Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects.

    Yi Ai;William Markesbery;Zhiming Zhang;Richard Grondin

  • Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys.

    Richard Grondin;Wayne A. Cass;Zhiming Zhang;John A. Stanford

  • Widespread suppression of huntingtin with convection-enhanced delivery of siRNA.

    David K. Stiles;Zhiming Zhang;Pei Ge;Brian Nelson

  • Trophic factor distribution predicts functional recovery in parkinsonian monkeys.

    Don M. Gash;Zhiming Zhang;Yi Ai;Richard Grondin

  • Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys.

    R. Grondin;Abdallah Hadj Tahar;Van Diep Doan;P. Ladure

  • Differential Regulation of Striatal Preproenkephalin and Preprotachykinin mRNA Levels in MPTP‐Lesioned Monkeys Chronically Treated with Dopamine D1 or D2 Receptor Agonists

    Morissette M;Grondin R;Goulet M;Bédard Pj

  • Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment.

    Frédéric Calon;Marc Morissette;Othman Ghribi;Martin Goulet

  • Dopamine-receptor stimulation: biobehavioral and biochemical consequences.

    Frédéric Calon;Abdallah Hadj Tahar;Pierre J. Blanchet;Marc Morissette

  • Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys

    Wayne A. Cass;Richard Grondin;Anders H. Andersen;Zhiming Zhang

  • Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.

    P. J. Blanchet;R. Grondin;P. J. Bédard

  • Motor Slowing and Parkinsonian Signs in Aging Rhesus Monkeys Mirror Human Aging

    Zhiming Zhang;Anders Andersen;Charles Smith;Richard Grondin

  • Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys.

    Navin Maswood;Richard Grondin;Zhiming Zhang;John A Stanford

  • Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms.

    Pierre J Blanchet;Frédéric Calon;Marc Morissette;Abdallah Hadj Tahar

  • D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys.

    Richard Grondin;Van Diep Doan;Laurent Grégoire;Paul J. Bédard

Frequent Co-Authors

Zhiming Zhang
Zhiming Zhang University of Kentucky
Don M. Gash
Don M. Gash University of Kentucky
Greg A. Gerhardt
Greg A. Gerhardt University of Kentucky
Paul J. Bédard
Paul J. Bédard Université Laval
Frédéric Calon
Frédéric Calon Université Laval
Marc Morissette
Marc Morissette Université Laval
Wayne A. Cass
Wayne A. Cass University of Kentucky
Nada M. Porter
Nada M. Porter University of Kentucky
Michael J. O'Neill
Michael J. O'Neill Eli Lilly (United States)
Brian T. Gold
Brian T. Gold University of Kentucky

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Neuroscience opens doors to many career paths, both in research and applied settings. For those interested in the clinical side, online programs such as psyd programs usa can prepare graduates for psychology practice or counseling careers with a neuroscience focus.

Another pathway is in marriage and family therapy, where a background in neuroscience can be highly valuable. If you're looking for flexible and efficient study options, consider accredited mft program choices online, often designed for fast completion.

Accelerated learning opportunities are available for those eager to enter the workforce quickly. Explore 2 year accelerated bachelor degrees in relevant fields that help you build foundational knowledge for neuroscience-related careers.

Salary potential can also be a deciding factor. Review your options with the best bachelor degrees for high-earning opportunities, many of which intersect with neuroscience, psychology, and healthcare professions.

Best Scientists Citing Richard Grondin

Trending Scientists

Recently Published Articles